Recombinant human erythropoietin (CHO Cell), Shanghai Chemo Wanbang Biophama Co Ltd

重组人促红素（CHO细胞）（上海凯茂生物医药有限公司）

Report date: 2023/10/19 16:46:30

Base Information

Drug NameRecombinant human erythropoietin (CHO Cell), Shanghai Chemo Wanbang Biophama Co Ltd
Drug Alias NameN/A
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaAnemia
Original Approved Country/TerritoryMainland China
Original Approved Date2023/09/28
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Kaimao Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Kaimao Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A